Jorge Velarde is a seasoned executive in the biotechnology and genomics sectors, currently serving as Chief Business Officer at Singular Genomics since October 2018, focusing on advancing science and medicine through genomics. In addition, Jorge holds a board member position at Kura Biotech, where dedication to resolving complex laboratory challenges is emphasized. Previous roles include Chief Executive Officer and President of BaseHealth, Inc. from January 2014 to January 2015, leading initiatives in integrated health management, and Vice President of Business Development at Illumina, Inc. from January 2001 to January 2012, overseeing business development and alliance management. Earlier experience includes roles in business development at Gen-Probe, Inc., and scientific contributions at Chugai BioPharmaceuticals and Louisiana State University. Jorge Velarde earned an MBA from the University of California, Irvine and a Bachelor of Science in Molecular Biology from Loyola University New Orleans.